Form 4: Staar Surgical CEO Receives Stock Grant
Insider Transaction (Form 4)
Warren Foust, President and CEO of Staar Surgical Co, reported multiple transactions in common stock on August 14, 2026.
Summary
- Option exercise/conversion: acquired 7,331 Common Stock on August 14, 2026; holds 93,887 after (Direct).
- Tax/exercise-price withholding: disposed of 3,730 Common Stock at $26.18 ($97,651) on August 14, 2026; holds 97,617 after (Direct).
- Option exercise/conversion: acquired 3,666 Common Stock on August 14, 2026; holds 93,951 after (Direct).
- Tax/exercise-price withholding: disposed of 1,865 Common Stock at $26.18 ($48,826) on August 14, 2026; holds 95,816 after (Direct).
- Grant/award: acquired 22,493 Restricted Stock Units on August 14, 2026; holds 22,493 after (Direct).
- Grant/award: acquired 40,471 Stock Option (right to buy) on August 14, 2026; holds 40,471 after (Direct).
- Grant/award: acquired 37,962 Stock Option (right to buy) on August 14, 2026; holds 37,962 after (Direct).
- Grant/award: acquired 131,830 Performance Stock Option (right to buy) on August 14, 2026; holds 131,830 after (Direct).
- Grant/award: acquired 123,659 Performance Stock Option (right to buy) on August 14, 2026; holds 123,659 after (Direct).
- Option exercise/conversion: acquired 7,331 Performance Stock Units on August 14, 2026; holds 93,887 after (Direct).
- Option exercise/conversion: acquired 3,666 Performance Stock Units on August 14, 2026; holds 97,553 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Warren Foust — Officer (President and CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-14 | Option exercise/conversion | Common Stock | 7,331 | — | — | 93,887 |
| 2026-08-14 | Tax/exercise-price withholding | Common Stock | 3,730 | $26 | $97.7K | 97,617 |
| 2026-08-14 | Option exercise/conversion | Common Stock | 3,666 | — | — | 93,951 |
| 2026-08-14 | Tax/exercise-price withholding | Common Stock | 1,865 | $26 | $48.8K | 95,816 |
| 2026-08-14 | Grant/award | Restricted Stock Units | 22,493 | — | — | 22,493 |
| 2026-08-14 | Grant/award | Stock Option (right to buy) | 40,471 | — | — | 40,471 |
| 2026-08-14 | Grant/award | Stock Option (right to buy) | 37,962 | — | — | 37,962 |
| 2026-08-14 | Grant/award | Performance Stock Option (right to buy) | 131,830 | — | — | 131,830 |
| 2026-08-14 | Grant/award | Performance Stock Option (right to buy) | 123,659 | — | — | 123,659 |
| 2026-08-14 | Option exercise/conversion | Performance Stock Units | 7,331 | — | — | 93,887 |
| 2026-08-14 | Option exercise/conversion | Performance Stock Units | 3,666 | — | — | 97,553 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-14 | Option exercise/conversion (7,331 shares) |
| 2026-08-14 | Tax/exercise-price withholding (3,730 shares) |
| 2026-08-14 | Option exercise/conversion (3,666 shares) |
| 2026-08-14 | Tax/exercise-price withholding (1,865 shares) |
| 2026-08-14 | Grant/award (22,493 shares) |
| 2026-08-14 | Grant/award (40,471 shares) |
| 2026-08-14 | Grant/award (37,962 shares) |
| 2026-08-14 | Grant/award (131,830 shares) |
| 2026-08-14 | Grant/award (123,659 shares) |
| 2026-08-14 | Option exercise/conversion (7,331 shares) |
| 2026-08-14 | Option exercise/conversion (3,666 shares) |
Keywords
insider transaction, Form 4, STAA, STAAR SURGICAL CO, neutral, Warren Foust
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.